3-hydroxyterphenyllin has been researched along with Diabetic Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Changsorn, K; Hiranmartsuwan, P; Kaewin, S; Muanprasat, C; Rukachaisirikul, V; Sungkaworn, T; Yaosanit, W | 1 |
1 other study(ies) available for 3-hydroxyterphenyllin and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Fungus-Derived 3-Hydroxyterphenyllin and Candidusin A Ameliorate Palmitic Acid-Induced Human Podocyte Injury via Anti-Oxidative and Anti-Apoptotic Mechanisms.
Topics: Apoptosis; Diabetic Nephropathies; Fungi; Humans; Palmitic Acid; Podocytes; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Terphenyl Compounds | 2022 |